What is Grey Market Premium (GMP) and Should You Trust It?
GMP is everywhere in IPO discussions — but few investors understand what it really measures, why it fails, and how to use it without being misled.
✅ Key Takeaways
- 1.GMP is the premium above the IPO issue price at which shares trade informally, before the IPO lists on an exchange.
- 2.The grey market is completely unregulated — there is no legal protection if a grey market trade goes wrong.
- 3.GMP is a sentiment indicator, not a prediction. Treat it as one data point, never as the primary decision driver.
- 4.GMP can be — and has been — deliberately manipulated, especially for small-cap and SME IPOs.
- 5.High GMP has frequently preceded weak or negative listing gains. Low GMP has preceded strong listings.
In This Guide
What GMP Actually Means
Grey Market Premium (GMP) is the price at which IPO shares trade in the informal, unofficial secondary market before the shares are officially allotted and listed on BSE or NSE.
It is expressed as a premium above the IPO issue price. If a company's IPO issue price is ₹100 and the grey market is trading the shares at ₹130, the GMP is ₹30 (or 30%).
The grey market exists because there is demand from investors who want to either buy IPO shares they did not receive in the allotment, or sell their allocation before the listing date to lock in an expected gain without waiting for the exchange to open trading.
How the Grey Market Operates
The grey market is entirely informal. Trades happen through phone calls, WhatsApp messages, and personal brokers who operate outside any regulatory framework. There is no central marketplace, no settlement guarantee, and no standard contract.
Settlement typically happens on the IPO listing day. If you bought grey market shares at a premium and the listing price is below your grey market cost, you bear that loss — and if your counterparty defaults, you have no legal recourse.
This makes grey market trading fundamentally different from exchange trading. On BSE or NSE, the exchange guarantees settlement. In the grey market, the deal is only as good as the person you are dealing with.
⚠️ Warning
Grey market transactions are not legally recognised. If you transact in the grey market and face a dispute or default, you cannot approach SEBI, the exchange, or any regulatory body for help. Civil courts are your only option, and the unstructured nature of these trades makes legal action extremely difficult.
Kostak Rate and Subject Sauda: Related Concepts
Two related terms appear frequently alongside GMP in IPO discussions:
ℹ️ Note
Kostak and Subject Sauda are entirely grey market constructs with no legal standing. They are common in retail IPO investment discussions in Gujarat and Maharashtra but are neither regulated nor recommended by TFN.
- ▸Kostak Rate: The price paid to buy an entire IPO application from an applicant, regardless of how many shares they are eventually allotted. If you applied for an IPO and received no allotment, you still collect the Kostak rate from the buyer. The Kostak rate varies based on subscription demand and allotment probability.
- ▸Subject Sauda (or "Subject to Sauda"): A deal struck on the condition that allotment happens. Unlike Kostak, Subject Sauda only triggers if the applicant actually receives an allotment. The price is typically higher than Kostak since the buyer is paying for guaranteed-allotted shares.
How to Interpret GMP Numbers
GMP is best read as a measure of current market sentiment — how optimistic or pessimistic informal market participants feel about the IPO at this moment.
💡 Tip
Negative GMP is actually more reliable than positive GMP. It is harder for market participants to drive artificial demand when sentiment is genuinely poor. A negative GMP is a meaningful warning signal that the market expects a weak listing.
| GMP Level | What It Signals | Reliability |
|---|---|---|
| Very high (>40% of issue price) | Strong retail enthusiasm; high subscription expected | Low — often manipulated at this level |
| Moderate (10–40%) | Positive sentiment; reasonable subscription likely | Moderate — reflects genuine demand more accurately |
| Low (0–10%) | Mild interest; uncertain subscription | Moderate to high — harder to manipulate in this range |
| Negative (below issue price) | Weak demand; below-issue-price listing expected | High — negative GMP is harder to fake and often predictive |
Why GMP Is Often Wrong
GMP has a notably poor track record as a listing price predictor, particularly at extremes. Several structural reasons explain this:
- ▸It is easily manipulated: A small group of operators can push GMP higher by conducting internal trades or spreading optimistic rumours. This is particularly common in SME IPOs where the number of grey market participants is small.
- ▸It reflects the last trade, not real demand: GMP represents the price of the most recent informal transaction, which may involve a tiny volume. It does not reflect the aggregate demand across all investors.
- ▸Sentiment shifts rapidly: GMP is taken during the subscription period or just before listing. Market conditions can shift dramatically overnight — a global sell-off, a negative news event, or sudden FII outflows can destroy a high GMP.
- ▸Allotment ratios matter: For heavily oversubscribed IPOs, most retail applicants get either 1 lot or no allotment. The actual floating supply on listing day differs significantly from GMP-period expectations.
- ▸Anchor investor sell-offs: Anchor investors have a 90-day lock-in except for 50% of their allocation, which can be sold on day 1. Large anchor sell-off on listing day has repeatedly caused prices to open below GMP.
How TFN Recommends Using GMP
GMP is a sentiment thermometer, not a valuation tool. Here is how to use it responsibly:
ℹ️ Note
TFN's IPO News Terminal shows GMP tags on news articles as a quick sentiment signal. Use these alongside company financials on the Companies page for a complete picture before applying to any IPO.
- ▸Use it as one of several inputs, not the deciding factor. Your primary analysis should be the company's financials, valuation relative to listed peers, management quality, and the purpose of IPO proceeds.
- ▸Weight negative GMP heavily. If GMP is negative or has dropped sharply from its peak, take that as a meaningful warning.
- ▸Ignore extreme positive GMP. A GMP above 50% of issue price is almost always partially manufactured and should trigger scepticism, not FOMO.
- ▸Track GMP trend, not just the number. A GMP falling from 40% to 20% in three days is more informative than a static 25% GMP — the falling trend suggests eroding sentiment.
- ▸Never transact in the grey market itself. Use GMP data only to inform your decision about participating in the official IPO.
Continue on TFN
Frequently Asked Questions
Where does GMP data come from?▾
GMP data is collected informally from grey market operators and broker networks — primarily in Gujarat, Maharashtra, and Rajasthan. There is no official source. Different websites may show different GMP values for the same IPO, reflecting regional variations.
Is it legal to participate in the grey market?▾
There is no specific law that criminalises grey market participation, but it is completely unregulated. SEBI has no jurisdiction over grey market transactions and cannot protect you if something goes wrong. Regulatory guidance consistently advises against it.
Does a high GMP guarantee listing gains?▾
No. High GMP has frequently been followed by disappointing listings — particularly for SME IPOs. GMP measures informal market sentiment, not fundamental value. Listing price is determined by real supply and demand on exchange on the listing day.
What is the difference between GMP and the listing price?▾
GMP is the informal pre-listing price in the grey market. Listing price is the official price at which the stock first trades on BSE or NSE. These can differ significantly — sometimes the listing price is much higher than implied by GMP; sometimes much lower.
Should I invest in an IPO based on GMP alone?▾
No. GMP is a weak and manipulable signal. Base your IPO investment decision on company fundamentals, valuation, peer comparison, and the quality of IPO proceeds usage. GMP can be one minor input but should never be the primary reason.
DISCLAIMER
This guide is for educational purposes only and does not constitute financial, legal, or tax advice. Information is believed to be accurate as of March 2026 but laws and regulations change. Always verify current rules with a qualified Chartered Accountant, legal advisor, or SEBI-registered investment advisor before making investment decisions. The Finance Network is not a SEBI-registered investment advisor and does not recommend specific securities.